CWM
BIIB icon

Congress Wealth Management’s Biogen BIIB Stock Holding History

Congress Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$516K Buy
4,106
+1,073
+35% +$134K 0.01% 914
2025
Q1 		$416K Buy
+3,033
New +$434K 0.01% 865

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Congress Wealth Management's BIIB Position: Q2 2025 in Review

Congress Wealth Management increased its Biogen (BIIB) stake by 35% in Q2 2025, buying an estimated $134K and bringing the position to 4,106 shares worth $516K. The position accounts for 0.01% of the portfolio, ranked #914.

Congress Wealth Management first reported a position in BIIB in Q1 2025 and has held it in 2 quarters since. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Congress Wealth Management held 4,106 shares of Biogen worth $516K as of Q2 2025.
  • Congress Wealth Management bought 1,073 Biogen shares in Q2 2025, an estimated $134K.
  • Biogen made up 0.01% of Congress Wealth Management's portfolio in Q2 2025, its #914 holding.
  • Congress Wealth Management first reported a position in Biogen in Q1 2025 and has held it in 2 quarters since.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.